GlassScriptPhysician profile
Michael F D'Angelo
NPI 1114969235
$120,414.36
in general payments reported to CMS, 2019-2025
52 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,750 · 2020: $1,223 · 2021: $8,490 · 2022: $49K · 2023: $30K · 2024: $13K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $51K · Food and Beverage: $6,620 · Consulting Fee: $1,138 · Travel and Lodging: $247 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $51,483.75 |
| Food and Beverage | $6,620.02 |
| Consulting Fee | $1,137.50 |
| Travel and Lodging | $246.92 |
| Education | $154.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $105,981.56 | 2021-2025 | Urolift, Barrigel |
| Arrow International, INC. | $5,100.00 | 2022 | |
| Neotract INC. | $2,067.67 | 2019-2020 | |
| Boston Scientific Corporation | $809.22 | 2019-2025 | Axonics, Lithovue, Ams 700 |
| Pfizer INC. | $459.66 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $444.28 | 2021-2025 | Prolaris, Myrisk |
| Calyxo, INC. | $442.68 | 2022-2024 | Cvac Aspiration System |
| Janssen Biotech, INC. | $434.90 | 2021-2025 | Erleada, Akeega |
| Ferring Pharmaceuticals INC. | $424.30 | 2024-2025 | Adstiladrin |
| Coloplast Corp | $413.50 | 2020-2025 | Titan |
| Abbvie INC. | $345.69 | 2019-2025 | Botox, Lupron Depot |
| Endo Pharmaceuticals INC. | $300.27 | 2019-2024 | Xiaflex, Aveed |
| Astellas Pharma US INC | $272.83 | 2019-2024 | Xtandi |
| Urogen Pharma, INC. | $242.97 | 2021-2025 | Jelmyto |
| Endo USA, INC. | $219.92 | 2024-2025 | Xiaflex |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $205.71 | 2024-2025 | Aquabeam System |
| Sumitomo Pharma America, INC. | $170.19 | 2023-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $143.79 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $133.76 | 2023 | Seglentis |
| Dendreon Pharmaceuticals LLC | $133.22 | 2021 | |
| Tolmar, INC. | $128.30 | 2023-2025 | Eligard, Jatenzo |
| Smith+Nephew, INC. | $124.57 | 2020-2025 | Stravix, Grafix Pl |
| Medtronic USA, INC. | $109.92 | 2019 | |
| Allergan, INC. | $103.73 | 2019-2021 | |
| Lumenis, INC | $93.25 | 2021 | |
| Novartis Pharmaceuticals Corporation | $83.70 | 2023-2025 | |
| Intuitive Surgical, INC. | $79.59 | 2023 | Da Vinci Surgical System |
| Myovant Sciences INC. | $74.00 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $67.94 | 2023 | Keytruda, Lynparza |
| Olympus America INC. | $61.79 | 2020-2024 | Itind System |
| Accord Healthcare, INC. | $61.46 | 2022-2023 | |
| Becton, Dickinson and Company | $60.73 | 2025 | Magic3 Go Intermittent Urinary Catheter, Purewick Female External Catheter |
| Axonics, INC. | $59.91 | 2023-2024 | Axonics |
| C. R. Bard, INC. & Subsidiaries | $55.92 | 2020-2021 | |
| Ambu INC. | $54.95 | 2020-2022 | |
| Antares Pharma, INC. | $48.92 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $44.40 | 2025 | Erleada, Pipeline |
| Rochester Medical Corporation | $41.07 | 2021-2022 | |
| Civco Medical Instruments | $35.93 | 2024 | |
| Edap Technomed INC | $33.91 | 2025 | |
| Verity Pharmaceuticals INC. | $32.54 | 2025 | Trelstar, Tlando |
| Astrazeneca Pharmaceuticals LP | $31.61 | 2020-2022 | |
| Alexion Pharmaceuticals, INC. | $26.01 | 2024 | Ultomiris |
| Gilead Sciences, INC. | $23.33 | 2025 | |
| Integra Lifesciences Corporation | $22.35 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Azurity Pharmaceuticals, INC. | $21.62 | 2025 | Azmiro |
| Pacira Pharmaceuticals Incorporated | $20.89 | 2022 | |
| Acerus Pharmaceuticals Corporation | $19.82 | 2020 | |
| Dentsply Ih INC. | $17.93 | 2021 | |
| Medtronic, INC. | $14.27 | 2021 | |
| Mimedx Group, INC. | $13.88 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,730.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael D'Angelo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.